IMAAVY (nipocalimab-aahu) Injection recall
FDA recall D-0016-2027 · initiated Sep 23, 2026
J&J INNOVATIVE MEDICINE recalled IMAAVY (nipocalimab-aahu) Injection in Sep 2026 — an FDA Class II recall (D-0016-2027) because Presence of particulate matter.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Presence of particulate matter.
Something got into the product
A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 49 vials
Details
- Product
- IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For Intravenous Infusion After Dilution, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044. NDC: 57894-800-01
- Recalling company
- J&J INNOVATIVE MEDICINE
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- OH
- Initiated
- Sep 23, 2026
- FDA report date
- Oct 14, 2026
This recall is linked to a product we cover: Imaavy →
Frequently asked
- Was IMAAVY (nipocalimab-aahu) Injection recalled?
- J&J INNOVATIVE MEDICINE recalled IMAAVY (nipocalimab-aahu) Injection in Sep 2026 — an FDA Class II recall (D-0016-2027) because Presence of particulate matter. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was IMAAVY (nipocalimab-aahu) Injection recalled?
- Per the FDA enforcement record, the reason for recall D-0016-2027 was: Presence of particulate matter.
- Is a recalled IMAAVY (nipocalimab-aahu) Injection dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of IMAAVY (nipocalimab-aahu) Injection are affected?
- Distributed: OH. The recall covers these lots — Lot JNYJ1208; Exp. 10/30/2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0016-2027.